4.6 Article

Apolipoprotein E genotype and mortality: Findings from the Cache County study

Journal

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
Volume 53, Issue 6, Pages 935-942

Publisher

WILEY
DOI: 10.1111/j.1532-5415.2005.53301.x

Keywords

apolipoprotein E; mortality; Alzheimer's disease; cardiovascular disease

Funding

  1. NIA NIH HHS [T32-AG-00029, AG-11380] Funding Source: Medline
  2. NIMH NIH HHS [T32-MH-14592] Funding Source: Medline

Ask authors/readers for more resources

OBJECTIVES: To evaluate the association between apolipoprotein E (apo E) epsilon 4 and mortality, the population attributable risk for mortality with epsilon 4, and relative contributions of cardiovascular disease (CVD) and Alzheimer's disease (AD). DESIGN: Population-based cohort study. SETTING: Community-based. PARTICIPANTS: Permanent residents of Cache County, Utah, aged 65 and older as of January 1, 1995. MEASUREMENTS: Participants were genotyped at the apo E locus using buccal-swab deoxyribonucleic acid. Cardiovascular health was ascertained using self- or proxy-report interviews at participants' residences. AD was diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised, and National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders criteria. Utah Department of Vital Statistics quarterly reports were reviewed to identify participants who died. RESULTS: Crude evaluations showed nonsignificantly greater risk of death for epsilon 2/2 (hazard ratio (HR)=1.66, 95% confidence interval (CI)=0.92-2.76) and epsilon 3/4 (HR=1.11, 95% CI=0.97-1.26) genotypes and significantly greater risk for epsilon 4/4 (HR=1.48, 95% CI=1.09-1.96). After adjustment for age, age(2), sex, and education, risks increased to 1.98 (95% CI=1.08-3.35), 1.28 (95% CI=1.12-1.46), and 2.02 (95% CI=1.47-2.71), respectively, compared with epsilon 3/3 genotypes. Adjustment for presence of any CVD did not change the risk of death for epsilon 3/4 and epsilon 4/4. Adjustment for AD reduced the risk of death for epsilon 3/4 (HR=1.13, 95% CI=0.99-1.30) and epsilon 4/4 (HR=1.59, 95% CI=1.15-2.14). The population attributable risk of death for epsilon 3/4 and epsilon 4/4 genotypes combined is estimated at 9.6%. CONCLUSION: These findings suggested that the epsilon 2/2, epsilon 3/4, and epsilon 4/4 genotypes have greater early mortality risks. Further analyses showed that AD partially mediates the association between epsilon 3/4, epsilon 4/4, and death.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available